Browsing: life science
The commitment to advancing the development of bexicaserin for patients with Developmental and Epileptic Encephalopathies (DEEs) is emphasized by Dr.…
The positive tumour response observed in the sixth patient has resulted in the initiation of additional recruitment for the ongoing…
The FDA has granted Fast Track Designation to Narmafotinib for the treatment of advanced pancreatic cancer. This designation is intended…
A Phase 1a trial of SZN-043 has shown promising results, indicating target engagement and Wnt-pathway mediated pharmacodynamic effects in the…
The Phase 1a trial of SZN-043 showed evidence of target engagement and Wnt-pathway mediated pharmacodynamic effects in the liver. Enrollment…